X-10449709-T-C
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 1P and 5B. PP5BS1_SupportingBS2
The NM_000381.4(MID1):āc.1663A>Gā(p.Ile555Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000108 in 1,199,830 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 3 hemizygotes in GnomAD. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000381.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MID1 | NM_000381.4 | c.1663A>G | p.Ile555Val | missense_variant | 10/10 | ENST00000317552.9 | NP_000372.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000268 AC: 3AN: 112000Hom.: 0 Cov.: 23 AF XY: 0.0000293 AC XY: 1AN XY: 34164
GnomAD3 exomes AF: 0.00000558 AC: 1AN: 179208Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 65020
GnomAD4 exome AF: 0.00000919 AC: 10AN: 1087830Hom.: 0 Cov.: 28 AF XY: 0.00000566 AC XY: 2AN XY: 353490
GnomAD4 genome AF: 0.0000268 AC: 3AN: 112000Hom.: 0 Cov.: 23 AF XY: 0.0000293 AC XY: 1AN XY: 34164
ClinVar
Submissions by phenotype
X-linked Opitz G/BBB syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Center for Human Genetics, Inc, Center for Human Genetics, Inc | Nov 01, 2016 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Sep 24, 2024 | Variant summary: MID1 c.1663A>G (p.Ile555Val) results in a conservative amino acid change located in the B30.2/SPRY domain (IPR001870) of the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 1.1e-05 in 1199830 control chromosomes, predominantly at a frequency of 1.8e-05 within the Non-Finnish European subpopulation and including 3 hemizygous males, in the gnomAD database. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.1663A>G has been reported in the literature in at least one hemizygote affected with Opitz G/BBB syndrome (e.g., Ferrentino_2007). These data do not allow any conclusion about variant significance. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication has been ascertained in the context of this evaluation (PMID: 17221865). ClinVar contains an entry for this variant (Variation ID: 547526). Based on the evidence outlined above, the variant was classified as VUS-possibly benign. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at